Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Aadi buys preclinical ADCs, sells Fyarro to reboot business
Aadi is transforming from a commercial business into a preclinical biotech by offloading its approved product and licensing ADCs for $44 million.
Nick Paul Taylor
Dec 20, 2024 3:54am
Fierce Biotech Fundraising Tracker: Ottimo, SiteOne & more
Dec 19, 2024 12:00pm
VC firm pens $608M deal to direct NGM MASH drug to rare disease
Dec 19, 2024 10:30am
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
Dec 19, 2024 6:58am
European VC raises $190M fund for early-stage biotechs
Dec 18, 2024 4:55pm
Novo Holdings-backed SiteOne charges up with $100M financing
Dec 18, 2024 7:00am
